BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 26977455)

  • 41. Use of point-of-care testing and early assessment model reduces length of stay for ambulatory patients in an emergency department.
    Kankaanpää M; Raitakari M; Muukkonen L; Gustafsson S; Heitto M; Palomäki A; Suojanen K; Harjola VP
    Scand J Trauma Resusc Emerg Med; 2016 Oct; 24(1):125. PubMed ID: 27756354
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Geospatial Science and Point-of-Care Testing: Creating Solutions for Population Access, Emergencies, Outbreaks, and Disasters.
    Kost GJ
    Front Public Health; 2019; 7():329. PubMed ID: 32039125
    [No Abstract]   [Full Text] [Related]  

  • 43. Measuring hot flashes: summary of a National Institutes of Health workshop.
    Miller HG; Li RM
    Mayo Clin Proc; 2004 Jun; 79(6):777-81. PubMed ID: 15182093
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Advancing the science of myocardial recovery with mechanical circulatory support: A Working Group of the National, Heart, Lung, and Blood Institute.
    Drakos SG; Pagani FD; Lundberg MS; Baldwin TJ
    J Thorac Cardiovasc Surg; 2017 Jul; 154(1):165-170. PubMed ID: 28633205
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Clinical governance: implications for point-of-care testing.
    Freedman DB
    Ann Clin Biochem; 2002 Sep; 39(Pt 5):421-3. PubMed ID: 12227847
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Usefulness of POCT in critical care medicine].
    Fukuda A; Ishida H; Kubota M; Kojima Y
    Rinsho Byori; 1999 Dec; 47(12):1113-8. PubMed ID: 10639820
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Does use of point-of-care testing improve cost-effectiveness of the NHS Health Check programme in the primary care setting? A cost-minimisation analysis.
    El-Osta A; Woringer M; Pizzo E; Verhoef T; Dickie C; Ni MZ; Huddy JR; Soljak M; Hanna GB; Majeed A
    BMJ Open; 2017 Aug; 7(8):e015494. PubMed ID: 28814583
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Point of Care Testing for Infectious Disease in Europe: A Scoping Review and Survey Study.
    Hocking L; George J; Broberg EK; Struelens MJ; Leitmeyer KC; Deshpande A; Parkinson S; Francombe J; Morley KI; de Carvalho Gomes H
    Front Public Health; 2021; 9():722943. PubMed ID: 34746078
    [No Abstract]   [Full Text] [Related]  

  • 49. Matching diagnostics development to clinical need: Target product profile development for a point of care test for community-acquired lower respiratory tract infection.
    Gal M; Francis NA; Hood K; Villacian J; Goossens H; Watkins A; Butler CC;
    PLoS One; 2018; 13(8):e0200531. PubMed ID: 30067760
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Improving the effectiveness of point of care tests for malaria and anaemia: a qualitative study across three Ghanaian antenatal clinics.
    Palmer T; Aiyenigba AO; Bates I; Okyere DD; Tagbor H; Ampofo GD
    BMC Health Serv Res; 2020 May; 20(1):444. PubMed ID: 32429903
    [TBL] [Abstract][Full Text] [Related]  

  • 51. How has the impact of 'care pathway technologies' on service integration in stroke care been measured and what is the strength of the evidence to support their effectiveness in this respect?
    Allen D; Rixson L
    Int J Evid Based Healthc; 2008 Mar; 6(1):78-110. PubMed ID: 21631815
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Research Priorities for Heart Failure With Preserved Ejection Fraction: National Heart, Lung, and Blood Institute Working Group Summary.
    Shah SJ; Borlaug BA; Kitzman DW; McCulloch AD; Blaxall BC; Agarwal R; Chirinos JA; Collins S; Deo RC; Gladwin MT; Granzier H; Hummel SL; Kass DA; Redfield MM; Sam F; Wang TJ; Desvigne-Nickens P; Adhikari BB
    Circulation; 2020 Mar; 141(12):1001-1026. PubMed ID: 32202936
    [TBL] [Abstract][Full Text] [Related]  

  • 53. POCT Analysts' Perspective: Practices and Wants for Improvement.
    Westgard SA; Goldschmidt HMJ; Ehrmeyer SS
    J Appl Lab Med; 2020 May; 5(3):480-493. PubMed ID: 32445365
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Modelling approaches for histology-independent cancer drugs to inform NICE appraisals: a systematic review and decision-framework.
    Murphy P; Glynn D; Dias S; Hodgson R; Claxton L; Beresford L; Cooper K; Tappenden P; Ennis K; Grosso A; Wright K; Cantrell A; Stevenson M; Palmer S
    Health Technol Assess; 2021 Dec; 25(76):1-228. PubMed ID: 34990339
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Concordance of three point of care testing devices with clinical chemistry laboratory standard assays and patient-reported outcomes of blood sampling methods.
    Yonel Z; Kuningas K; Sharma P; Dutton M; Jalal Z; Cockwell P; Webber J; Narendran P; Dietrich T; Chapple ILC
    BMC Med Inform Decis Mak; 2022 Sep; 22(1):248. PubMed ID: 36138408
    [TBL] [Abstract][Full Text] [Related]  

  • 56. A state-level needs analysis of community pharmacy point-of-care testing.
    Gallimore CE; Porter AL; Barnett SG; Portillo E; Zorek JA
    J Am Pharm Assoc (2003); 2021; 61(3):e93-e98. PubMed ID: 33431252
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Report of the National Heart, Lung, and Blood Institute Working Group on Hypertension: Barriers to Translation.
    Sigmund CD; Carey RM; Appel LJ; Arnett DK; Bosworth HB; Cushman WC; Galis ZS; Green Parker M; Hall JE; Harrison DG; McDonough AA; Nicastro HL; Oparil S; Osborn JW; Raizada MK; Wright JD; Oh YS
    Hypertension; 2020 Apr; 75(4):902-917. PubMed ID: 32063061
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Advancing the Science of Myocardial Recovery With Mechanical Circulatory Support: A Working Group of the National, Heart, Lung and Blood Institute.
    Drakos SG; Pagani FD; Lundberg MS; Baldwin JT
    J Card Fail; 2017 May; 23(5):416-421. PubMed ID: 28433665
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Implementation of HbA1c Point of Care Testing in 3 German Medical Practices: Impact on Workflow and Physician, Staff, and Patient Satisfaction.
    Patzer KH; Ardjomand P; Göhring K; Klempt G; Patzelt A; Redzich M; Zebrowski M; Emmerich S; Schnell O
    J Diabetes Sci Technol; 2018 May; 12(3):687-694. PubMed ID: 29532694
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Community paramedic point of care testing: validity and usability of two commercially available devices.
    Blanchard IE; Kozicky R; Dalgarno D; Simms J; Goulder S; Williamson TS; Biesbroek S; Page L; Leaman K; Snozyk S; Redman L; Spackman K; Doig CJ; Lang ES; Lazarenko G
    BMC Emerg Med; 2019 May; 19(1):30. PubMed ID: 31046680
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.